Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10721 (
c-kit
)
6,575
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In search of autoantigen-presenting cells that prime the pathogenic autoantibody-inducing Th cells of
lupus
, we found that CD41(+)CD151(+) cells among Lineage(-) (Lin(-)) CD117(+) (
c-Kit
(+)) CX3CR1(-) splenocytes depleted of known APCs were most proficient in presenting nuclear autoantigens from apoptotic cells to induce selectively an autoimmune Th17 response in different
lupus
-prone mouse strains. The new APCs have properties resembling megakaryocyte and/or bipotent megakaryocyte/erythroid progenitors of bone marrow, hence they are referred to as MM cells in this study. The MM cells produce requisite cytokines, but they require contact for optimal Th17 induction upon nucleosome feeding, and can induce Th17 only before undergoing differentiation to become
c-Kit
(-)CD41(+) cells. The MM cells expand up to 10-fold in peripheral blood of
lupus
patients and 49-fold in spleens of
lupus
mice preceding disease activity; they accelerate
lupus
in vivo and break tolerance in normal mice, inducing autoimmune Th17 cells. MM cells also cause Th17 skewing to foreign Ag in normal mice without Th17-polarizing culture conditions. Several molecules in MM cells are targets for blocking of autoimmunization. This study advances our understanding of
lupus
pathogenesis and Th17 differentiation biology by characterizing a novel category of APC.
...
PMID:Megakaryocyte progenitors are the main APCs inducing Th17 response to lupus autoantigens and foreign antigens. 2256 Nov 52
The function of mast cells in allergic and organ-specific autoimmune responses is highly controversial. In the current study, we aimed to dissect the role of mast cells in systemic autoimmunity in the B6(lpr/lpr) mouse, a spontaneous model of systemic lupus erythematosus. B6(lpr/lpr) mice were interbred with C57Bl/6-Kit(W-sh/W-sh) (Wsh) mice, resulting in mast cell deficiency. The offspring from this cross (Lpr/Wsh mice) developed symptoms of
lupus
of the same severity as B6(lpr/lpr) mice. Loss of mast cells on the Lpr background did not alter autoantibody production, proteinuria, the composition of T and B cell populations or autoimmune pathology. Reduced
c-Kit
expression did drive expanded splenomegaly and impeded interleukin-4 production by CD4(+) cells, suggesting minor functions for mast cells. In general, we conclude that mast cell deficiency and
c-Kit
deficiency do not play a role in the pathogenesis of
lupus
in B6(lpr/lpr) mice.
...
PMID:Lpr-induced systemic autoimmunity is unaffected by mast cell deficiency. 2584 40